Ibutilide fumarate injection
This code is not in the latest file (4Q26). It was last listed in 4Q21.
Payment limit per 1 MG, by effective quarter, 1Q21 to 4Q21. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.Products billed under J1742
No NDCs mapped to this code in the 4Q26 crosswalk.
Every quarter
| Quarter | Payment limit | Change | Billing unit | Description | Source file |
|---|---|---|---|---|---|
| 4Q21 | $205.061 | −$21.04 | 1 MG | Ibutilide fumarate injection | v1, posted June 2, 2022 |
| 3Q21 | $226.101 | −$36.311 | 1 MG | Ibutilide fumarate injection | v1, posted June 2, 2022 |
| 2Q21 | $262.412 | −$10.744 | 1 MG | Ibutilide fumarate injection | v1, posted March 1, 2022 |
| 1Q21 | $273.156 | – | 1 MG | Ibutilide fumarate injection | v1, posted December 10, 2021 |
“Change” is the difference from the previous quarter, shown only when both quarters have a payment limit and the billing unit is the same. “vs. last quarter” and “vs. a year ago” follow the same rule.
CMS source files
- 4Q21: 2022-06-02_october-2021-asp-pricing-file.zipposted June 2, 2022
- 3Q21: 2022-06-02_july-2021-asp-pricing-file.zipposted June 2, 2022
- 2Q21: 2022-03-01_april-2021-asp-pricing-file.zipposted March 1, 2022
- 1Q21: 2021-12-10_january-2021-asp-pricing-file.zipposted December 10, 2021